AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
TRANSCRIPTIONAL REGULATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR BY CYCLIC-AMP IN PL-21 HUMAN MYELOID-LEUKEMIA CELLS - COMPARISON WITH THE REGULATION BY PHORBOL-MYRISTATE ACETATE
Authors: NIIYA K OZAWA T TSUZAWA T UESHIMA S MATSUO O SAKURAGAWA N
Citation: K. Niiya et al., TRANSCRIPTIONAL REGULATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR BY CYCLIC-AMP IN PL-21 HUMAN MYELOID-LEUKEMIA CELLS - COMPARISON WITH THE REGULATION BY PHORBOL-MYRISTATE ACETATE, Thrombosis and haemostasis, 79(3), 1998, pp. 574-578
FACTOR-VII MORIOKA (FVII L-26P) - A HOMOZYGOUS MISSENSE MUTATION IN THE SIGNAL SEQUENCE IDENTIFIED IN A PATIENT WITH FACTOR-VII DEFICIENCY
Authors: OZAWA T TAKIKAWA Y NIIYA K EJIRI N SUZUKI K SATO S SAKURAGAWA N
Citation: T. Ozawa et al., FACTOR-VII MORIOKA (FVII L-26P) - A HOMOZYGOUS MISSENSE MUTATION IN THE SIGNAL SEQUENCE IDENTIFIED IN A PATIENT WITH FACTOR-VII DEFICIENCY, British Journal of Haematology, 101(1), 1998, pp. 47-49
EFFICACY OF ANTITHROMBIN CONCENTRATES IN TREATMENT FOR ASTHMATIC SYMPTOMS COMPLICATED IN ANTITHROMBIN ABNORMALITY WITH NO HEPARIN-BINDING ACTIVITY
Authors: YOSHIDA Y NIIYA K MARUYAMA M OOSAKI R FUJISHITA T KOBAYASHI M SAKURAGAWA N
Citation: Y. Yoshida et al., EFFICACY OF ANTITHROMBIN CONCENTRATES IN TREATMENT FOR ASTHMATIC SYMPTOMS COMPLICATED IN ANTITHROMBIN ABNORMALITY WITH NO HEPARIN-BINDING ACTIVITY, Clinical and applied thrombosis/hemostasis, 3(4), 1997, pp. 288-289
FACTOR-VII DEFICIENCY INDUCED BY A HOMOZYGOUS MISSENSE MUTATION THR359 MET (FACTOR-VII TOYAMA)
Authors: SAKURAGAWA N OZAWA T NIIYA K HIGUCHI W
Citation: N. Sakuragawa et al., FACTOR-VII DEFICIENCY INDUCED BY A HOMOZYGOUS MISSENSE MUTATION THR359 MET (FACTOR-VII TOYAMA), Thrombosis and haemostasis, 1997, pp. 1687-1687
DNA ANALYSIS OF 4 JAPANESE FAMILIES WITH TYPE-I ANTITHROMBIN DEFICIENCY
Authors: OZAWA T NIIYA K HIGUCHI W SAKURAGAWA N
Citation: T. Ozawa et al., DNA ANALYSIS OF 4 JAPANESE FAMILIES WITH TYPE-I ANTITHROMBIN DEFICIENCY, Thrombosis and haemostasis, 1997, pp. 1767-1767
A NOVEL POLYMORPHISM IN EXON IN OF THE FACTOR-V GENE INDUCING AN AMINO-ACID REPLACEMENT OF ARGININE TO LYSINE AT CODON-485
Authors: OZAWA T NIIYA K EJIRI N SAKURAGAWA N
Citation: T. Ozawa et al., A NOVEL POLYMORPHISM IN EXON IN OF THE FACTOR-V GENE INDUCING AN AMINO-ACID REPLACEMENT OF ARGININE TO LYSINE AT CODON-485, Thrombosis and haemostasis, 78(5), 1997, pp. 1419-1420
FACTOR-VII TOYAMA (THR-359-MET) - A HOMOZYGOUS MISSENSE MUTATION CAUSING SEVERE TYPE-I DEFICIENCY
Authors: OZAWA T NIIYA K HIGUCHI W SAKURAGAWA N
Citation: T. Ozawa et al., FACTOR-VII TOYAMA (THR-359-MET) - A HOMOZYGOUS MISSENSE MUTATION CAUSING SEVERE TYPE-I DEFICIENCY, Thrombosis and haemostasis, 78(3), 1997, pp. 987-989
ANTITHROMBIN MORIOKA (CYS 95-ARG) - A NOVEL MISSENSE MUTATION CAUSINGTYPE-I ANTITHROMBIN DEFICIENCY
Authors: OZAWA T TAKIKAWA Y NIIYA K FUJIWARA T SUZUKI K SATO S SAKURAGAWA N
Citation: T. Ozawa et al., ANTITHROMBIN MORIOKA (CYS 95-ARG) - A NOVEL MISSENSE MUTATION CAUSINGTYPE-I ANTITHROMBIN DEFICIENCY, Thrombosis and haemostasis, 77(2), 1997, pp. 403-403
CALCIUM SPIRULAN AS AN INDUCER OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN HUMAN FETAL LUNG FIBROBLASTS
Authors: HAYAKAWA Y HAYASHI T HAYASHI K OZAWA T NIIYA K SAKURAGAWA N
Citation: Y. Hayakawa et al., CALCIUM SPIRULAN AS AN INDUCER OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN HUMAN FETAL LUNG FIBROBLASTS, Biochimica et biophysica acta. Molecular cell research, 1355(3), 1997, pp. 241-247
A NOVEL 4 BASE-PAIR DELETION MUTATION INDUCING TYPE-I ANTITHROMBIN DEFICIENCY
Authors: OZAWA T NIIYA K INOUE N KAWAHARA N NAKATSUKA M TADA K KUDO T SAKURAGAWA N
Citation: T. Ozawa et al., A NOVEL 4 BASE-PAIR DELETION MUTATION INDUCING TYPE-I ANTITHROMBIN DEFICIENCY, Thrombosis research, 85(6), 1997, pp. 515-517
HEPARIN-COFACTOR II-DEPENDENT ANTITHROMBIN ACTIVITY OF CALCIUM SPIRULAN
Authors: HAYAKAWA Y HAYASHI T HAYASHI K HAYASHI T OZAWA T NIIYA K SAKURAGAWA N
Citation: Y. Hayakawa et al., HEPARIN-COFACTOR II-DEPENDENT ANTITHROMBIN ACTIVITY OF CALCIUM SPIRULAN, Blood coagulation & fibrinolysis, 7(5), 1996, pp. 554-560
ISOLATED RECOMBINANT DOMAIN OF VON-WILLEBRAND-FACTOR DISPLAYING INCREASED SENSITIVITY TO RISTOCETIN
Authors: HAYASHI T WARE J NIIYA K SAKURAGAWA N
Citation: T. Hayashi et al., ISOLATED RECOMBINANT DOMAIN OF VON-WILLEBRAND-FACTOR DISPLAYING INCREASED SENSITIVITY TO RISTOCETIN, American journal of hematology, 52(4), 1996, pp. 248-253
INHIBITORY EFFECT OF A SYNTHETIC PROSTACYCLIN ANALOG, BERAPROST, ON UROKINASE-TYPE PLASMINOGEN-ACTIVATOR EXPRESSION IN RC-K8 HUMAN LYMPHOMA-CELLS
Authors: NOMURA N NIIYA K SHINBO M OZAWA T HAYAKAWA Y HIGASHIYAMA K FUJIMAKI M SAKURAGAWA N
Citation: N. Nomura et al., INHIBITORY EFFECT OF A SYNTHETIC PROSTACYCLIN ANALOG, BERAPROST, ON UROKINASE-TYPE PLASMINOGEN-ACTIVATOR EXPRESSION IN RC-K8 HUMAN LYMPHOMA-CELLS, Thrombosis and haemostasis, 75(6), 1996, pp. 928-932
THE PRODUCTION OF HEPARIN-COFACTOR-II IS NOT REGULATED BY INFLAMMATORY CYTOKINES IN HUMAN HEPATOMA-CELLS - COMPARISON WITH PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1
Authors: KOIKE C HAYAKAWA Y NIIYA K SAKURAGAWA N SASAKI H
Citation: C. Koike et al., THE PRODUCTION OF HEPARIN-COFACTOR-II IS NOT REGULATED BY INFLAMMATORY CYTOKINES IN HUMAN HEPATOMA-CELLS - COMPARISON WITH PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1, Thrombosis and haemostasis, 75(2), 1996, pp. 298-302
INDUCTION OF C-FOS PROTOONCOGENE TRANSCRIPTION AND APOPTOSIS BY DELTA(12)-PROSTAGLANDIN J(2) IN HUMAN PL-21 MYELOID-LEUKEMIA AND RC-K8 PRE-B LYMPHOMA-CELLS
Authors: HIGASHIYAMA K NIIYA K OZAWA T HAYAKAWA Y FUJIMAKI M SAKURAGAWA N
Citation: K. Higashiyama et al., INDUCTION OF C-FOS PROTOONCOGENE TRANSCRIPTION AND APOPTOSIS BY DELTA(12)-PROSTAGLANDIN J(2) IN HUMAN PL-21 MYELOID-LEUKEMIA AND RC-K8 PRE-B LYMPHOMA-CELLS, Prostaglandins, 52(3), 1996, pp. 143-156
ABSENCE OF FACTOR-V LEIDEN IN THE JAPANESE
Authors: OZAWA T NIIYA K SAKURAGAWA N
Citation: T. Ozawa et al., ABSENCE OF FACTOR-V LEIDEN IN THE JAPANESE, Thrombosis research, 81(5), 1996, pp. 595-596
SELECTIVE ACTIVATION OF HEPARIN-COFACTOR-II BY A SULFATED POLYSACCHARIDE ISOLATED FROM THE LEAVES OF ARTEMISIA-PRINCEPS
Authors: HAYAKAWA Y HAYASHI T HAYASHI T NIIYA K SAKURAGAWA N
Citation: Y. Hayakawa et al., SELECTIVE ACTIVATION OF HEPARIN-COFACTOR-II BY A SULFATED POLYSACCHARIDE ISOLATED FROM THE LEAVES OF ARTEMISIA-PRINCEPS, Blood coagulation & fibrinolysis, 6(7), 1995, pp. 643-649
CARBAZOCHROME SODIUM-SULFONATE (AC-17) DECREASES THE ACCUMULATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN CULTURE-MEDIUM OF HUMAN UMBILICALVEIN ENDOTHELIAL-CELLS
Authors: MATSUMOTO Y HAYASHI T HAYAKAWA Y SHINBO M NIIYA K SAKURAGAWA N
Citation: Y. Matsumoto et al., CARBAZOCHROME SODIUM-SULFONATE (AC-17) DECREASES THE ACCUMULATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN CULTURE-MEDIUM OF HUMAN UMBILICALVEIN ENDOTHELIAL-CELLS, Blood coagulation & fibrinolysis, 6(3), 1995, pp. 233-238
SEQUENTIAL-CHANGES IN THE DISTRIBUTION OF TYPE-I AND TYPE-III COLLAGENS IN THE INFARCT ZONE - IMMUNOHISTOCHEMICAL STUDY OF EXPERIMENTAL MYOCARDIAL-INFARCTION IN THE RAT
Authors: INOUE K KUSACHI S NIIYA K KAJIKAWA Y TSUJI T
Citation: K. Inoue et al., SEQUENTIAL-CHANGES IN THE DISTRIBUTION OF TYPE-I AND TYPE-III COLLAGENS IN THE INFARCT ZONE - IMMUNOHISTOCHEMICAL STUDY OF EXPERIMENTAL MYOCARDIAL-INFARCTION IN THE RAT, Coronary artery disease, 6(2), 1995, pp. 153-158
MODULATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR GENE-EXPRESSION BYINFLAMMATORY CYTOKINES IN HUMAN PRE-B LYMPHOMA CELL-LINE RC-K8
Authors: NIIYA K SHINBO M OZAWA T HAYAKAWA Y SAKURAGAWA N
Citation: K. Niiya et al., MODULATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR GENE-EXPRESSION BYINFLAMMATORY CYTOKINES IN HUMAN PRE-B LYMPHOMA CELL-LINE RC-K8, Thrombosis and haemostasis, 74(6), 1995, pp. 1511-1515
TRANSCRIPTIONAL REGULATION OF TISSUE-TYPE AND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR GENES BY THROMBIN IN HUMAN FETAL LUNG FIBROBLASTS
Authors: HAYAKAWA Y TAZAWA S ISHIKAWA T NIIYA K SAKURAGAWA N
Citation: Y. Hayakawa et al., TRANSCRIPTIONAL REGULATION OF TISSUE-TYPE AND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR GENES BY THROMBIN IN HUMAN FETAL LUNG FIBROBLASTS, Thrombosis and haemostasis, 74(2), 1995, pp. 704-710
PARTIAL-PURIFICATION AND CHARACTERIZATION OF THE ARTEMISIA LEAF EXTRACT THAT INACTIVATES THROMBIN THROUGH THE ACTIVATION OF HEPARIN COFACTOR-II
Authors: HAYASHI T HAYAKAWA Y HAYASHI T NIIYA K SAKURAGAWA N
Citation: T. Hayashi et al., PARTIAL-PURIFICATION AND CHARACTERIZATION OF THE ARTEMISIA LEAF EXTRACT THAT INACTIVATES THROMBIN THROUGH THE ACTIVATION OF HEPARIN COFACTOR-II, Thrombosis and haemostasis, 73(6), 1995, pp. 1352-1352
PROTEIN-KINASE ACTIVITY-DEPENDENT AND INDEPENDENT MECHANISMS OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR GENE-REGULATION BY CAMP IN HUMAN PRE-BLYMPHOMA CELL-LINE RC-K8
Authors: NIIYA K ALMOKDAD M SHINBO M HAYAKAWA Y SAKURAGAWA N
Citation: K. Niiya et al., PROTEIN-KINASE ACTIVITY-DEPENDENT AND INDEPENDENT MECHANISMS OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR GENE-REGULATION BY CAMP IN HUMAN PRE-BLYMPHOMA CELL-LINE RC-K8, Thrombosis and haemostasis, 73(6), 1995, pp. 1411-1411
PROTEIN-KINASE ACTIVITY-DEPENDENT INHIBITION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR GENE-TRANSCRIPTION BY CYCLIC-AMP IN HUMAN PRE-B LYMPHOMA CELL-LINE RC-K8
Authors: SHINBO M NIIYA K ALMOKDAD M HAYAKAWA Y HIRAGA K FUJIMAKI M SAKURAGAWA N
Citation: M. Shinbo et al., PROTEIN-KINASE ACTIVITY-DEPENDENT INHIBITION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR GENE-TRANSCRIPTION BY CYCLIC-AMP IN HUMAN PRE-B LYMPHOMA CELL-LINE RC-K8, Biochimica et biophysica acta. Molecular cell research, 1268(3), 1995, pp. 293-299
CHANGES IN EXTRACELLULAR-MATRIX COMPONENTS IN CARDIOMYOPATHIC SYRIAN-HAMSTER, BIO-14.6
Authors: NOGAMI K KUSACHI S NIIYA K MORITANI H TSUJI T
Citation: K. Nogami et al., CHANGES IN EXTRACELLULAR-MATRIX COMPONENTS IN CARDIOMYOPATHIC SYRIAN-HAMSTER, BIO-14.6, Japanese Circulation Journal, 59(9), 1995, pp. 631-640
Risultati: 1-25 | 26-38